MYOS RENS Technology Inc. announced positive top-line results from a randomized, double-blind, placebo-controlled study by Kansas State University evaluating the impact of Fortetropin on attenuating muscle atrophy following a common surgical procedure known as tibial-plateau leveling osteotomy ("TPLO") in 100 dogs. In the weeks that follow TPLO surgery, immobilization of the dog's limb is required and the operated limb frequently shows significant muscle loss due to muscle disuse atrophy. Key findings of the study were: Fortetropin prevented the loss of muscle mass in these dogs as measured by the thigh circumference in their affected and unaffected limbs. Fortetropin-supplemented dogs had a more significant improvement in percentage of weight supported by the affected limb as determined by force plate stance analysis (more rapid return to normal stance force distribution) than the placebo group. Fortetropin prevented a rise in serum myostatin levels. Myostatin is a protein that prevents muscle growth.